Emergent BioSolutions Inc.
Hedge Funds Holdings
Last updated:
Emergent BioSolutions Inc.‘s stocks are currently a part of 170 hedge funds’ portfolios, which represents 65.17% of the total amount of its stocks outstanding. This makes up a total of 32.58M shares of Emergent BioSolutions Inc.. Compared to the previous quarter, the number fell by -20.20% or -8.24M shares fewer. As for the holding position changes, 40.59% (69) of current hedge fund investors increased the number of shares held, 37.06% (63) of current holders sold a part of the shares held, and 26.47% (45) closed the holdings completely. 18 hedge funds are new holders of Emergent BioSolutions Inc. stock in Q3 2022, it is 10.59% of total holders.
Hedge funds holding Emergent BioSolutions (Q4 2017 – Q3 2022)
| Q4 2017 | 234 |
|---|---|
| Q1 2018 | 269 |
| Q2 2018 | 256 |
| Q3 2018 | 270 |
| Q4 2018 | 294 |
| Q1 2019 | 269 |
| Q2 2019 | 231 |
| Q3 2019 | 242 |
| Q4 2019 | 234 |
| Q1 2020 | 260 |
| Q2 2020 | 293 |
| Q3 2020 | 353 |
| Q4 2020 | 347 |
| Q1 2021 | 334 |
| Q2 2021 | 284 |
| Q3 2021 | 272 |
| Q4 2021 | 245 |
| Q1 2022 | 240 |
| Q2 2022 | 218 |
| Q3 2022 | 170 |
Hedge funds changes in Emergent BioSolutions positions (Q4 2017 – Q3 2022)
| Q4 2017 | 53 | 101 | 60 | 12 | 8 |
|---|---|---|---|---|---|
| Q1 2018 | 55 | 98 | 79 | 16 | 21 |
| Q2 2018 | 19 | 103 | 97 | 32 | 5 |
| Q3 2018 | 37 | 92 | 105 | 21 | 15 |
| Q4 2018 | 53 | 104 | 105 | 29 | 3 |
| Q1 2019 | 34 | 105 | 89 | 59 | -18 |
| Q2 2019 | 28 | 92 | 86 | 61 | -36 |
| Q3 2019 | 33 | 89 | 89 | 21 | 10 |
| Q4 2019 | 21 | 76 | 96 | 21 | 20 |
| Q1 2020 | 49 | 85 | 96 | 21 | 9 |
| Q2 2020 | 61 | 97 | 110 | 26 | -1 |
| Q3 2020 | 87 | 109 | 136 | 25 | -4 |
| Q4 2020 | 57 | 154 | 107 | 61 | -32 |
| Q1 2021 | 42 | 123 | 137 | 49 | -17 |
| Q2 2021 | 31 | 106 | 109 | 81 | -43 |
| Q3 2021 | 22 | 107 | 96 | 30 | 17 |
| Q4 2021 | 43 | 88 | 90 | 69 | -45 |
| Q1 2022 | 44 | 74 | 93 | 46 | -17 |
| Q2 2022 | 20 | 63 | 98 | 39 | -2 |
| Q3 2022 | 18 | 69 | 63 | 45 | -25 |
Hedge funds changes in Emergent BioSolutions stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 684,000 | 1,293,000 |
|---|---|---|
| Q1 2018 | 1,360,000 | 0 |
| Q2 2018 | 212,000 | 348,000 |
| Q3 2018 | 3,219,000 | 2,219,000 |
| Q4 2018 | 3,061,000 | 1,096,000 |
| Q1 2019 | 1,707,000 | 1,920,000 |
| Q2 2019 | 53,000 | 43,000 |
| Q3 2019 | 371,000 | 2,749,000 |
| Q4 2019 | 582,000 | 2,664,000 |
| Q1 2020 | 1,486,000 | 2,360,000 |
| Q2 2020 | 7,430,000 | 4,854,000 |
| Q3 2020 | 11,446,000 | 7,258,000 |
| Q4 2020 | 18,560,000 | 18,387,000 |
| Q1 2021 | 12,800,000 | 12,836,000 |
| Q2 2021 | 11,432,000 | 15,776,000 |
| Q3 2021 | 5,880,000 | 5,789,000 |
| Q4 2021 | 6,645,000 | 6,484,000 |
| Q1 2022 | 4,923,000 | 2,666,000 |
| Q2 2022 | 5,365,000 | 1,522,000 |
| Q3 2022 | 1,287,000 | 1,649,000 |